<?xml version="1.0" encoding="UTF-8"?>
<p>The common features of recently tested extracts (
 <italic>B. alba L., Boswellia serrata Roxb. ex Colebr., Curcuma longa L., E. senticosus</italic> (
 <italic>Rupr. &amp; Maxim</italic>.) 
 <italic>Maxim, Rhaponticum carthamoides</italic> (
 <italic>Willd</italic>.) 
 <italic>Iljin</italic>, 
 <italic>R. rosea L., and W. somnifera</italic> (
 <italic>L</italic>.) 
 <italic>Dunal</italic>) are related to the downregulation of 
 <italic>ALOX12</italic>, which is also associated with the neuroprotective action of these medicinal plants as well as their potential benefits in neurodegenerative diseases.
 <xref rid="med21743-bib-0452" ref-type="ref">
  <sup>452</sup>
 </xref>
</p>
